These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

659 related articles for article (PubMed ID: 31355391)

  • 1. Antibody-guided nanomedicines as novel breakthrough therapeutic, diagnostic and theranostic tools.
    Farahavar G; Abolmaali SS; Gholijani N; Nejatollahi F
    Biomater Sci; 2019 Oct; 7(10):4000-4016. PubMed ID: 31355391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
    Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
    Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
    Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
    Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomedical Applications of Nanomaterials as Therapeutics.
    Ng CT; Baeg GH; Yu LE; Ong CN; Bay BH
    Curr Med Chem; 2018; 25(12):1409-1419. PubMed ID: 28393698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbon nanomaterials as versatile platforms for theranostic applications.
    Kim M; Jang J; Cha C
    Drug Discov Today; 2017 Sep; 22(9):1430-1437. PubMed ID: 28533188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2D Nanomaterials for Cancer Theranostic Applications.
    Cheng L; Wang X; Gong F; Liu T; Liu Z
    Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theranostic nanomedicine.
    Lammers T; Aime S; Hennink WE; Storm G; Kiessling F
    Acc Chem Res; 2011 Oct; 44(10):1029-38. PubMed ID: 21545096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and diagnostic potential of nanomaterials for enhanced biomedical applications.
    Abd Elkodous M; El-Sayyad GS; Abdelrahman IY; El-Bastawisy HS; Mohamed AE; Mosallam FM; Nasser HA; Gobara M; Baraka A; Elsayed MA; El-Batal AI
    Colloids Surf B Biointerfaces; 2019 Aug; 180():411-428. PubMed ID: 31085460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox-responsive theranostic nanoplatforms based on inorganic nanomaterials.
    Han L; Zhang XY; Wang YL; Li X; Yang XH; Huang M; Hu K; Li LH; Wei Y
    J Control Release; 2017 Aug; 259():40-52. PubMed ID: 28288893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine.
    Zhang XQ; Xu X; Bertrand N; Pridgen E; Swami A; Farokhzad OC
    Adv Drug Deliv Rev; 2012 Oct; 64(13):1363-84. PubMed ID: 22917779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging inorganic nanomaterials for pancreatic cancer diagnosis and treatment.
    Yang F; Jin C; Subedi S; Lee CL; Wang Q; Jiang Y; Li J; Di Y; Fu D
    Cancer Treat Rev; 2012 Oct; 38(6):566-79. PubMed ID: 22655679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein adsorption onto nanomaterials engineered for theranostic applications.
    Nienhaus K; Xue Y; Shang L; Nienhaus GU
    Nanotechnology; 2022 Apr; 33(26):. PubMed ID: 35294940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives.
    Rehan F; Zhang M; Fang J; Greish K
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies.
    Howard CB; Fletcher N; Houston ZH; Fuchs AV; Boase NR; Simpson JD; Raftery LJ; Ruder T; Jones ML; de Bakker CJ; Mahler SM; Thurecht KJ
    Adv Healthc Mater; 2016 Aug; 5(16):2055-68. PubMed ID: 27283923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical and biochemical insights on DNA structures in artificial and living systems.
    Chen N; Li J; Song H; Chao J; Huang Q; Fan C
    Acc Chem Res; 2014 Jun; 47(6):1720-30. PubMed ID: 24588263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicines for Renal Management: From Imaging to Treatment.
    Jiang D; Rosenkrans ZT; Ni D; Lin J; Huang P; Cai W
    Acc Chem Res; 2020 Sep; 53(9):1869-1880. PubMed ID: 32786331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional magnetic hybrid nanomaterials for biomedical diagnosis and treatment.
    Tian X; Zhang L; Yang M; Bai L; Dai Y; Yu Z; Pan Y
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jan; 10(1):. PubMed ID: 28471067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-Targeted Nanotheranostics: Recent Advances and Perspectives.
    Ma Y; Huang J; Song S; Chen H; Zhang Z
    Small; 2016 Sep; 12(36):4936-4954. PubMed ID: 27150247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.